BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The American Association for Homeopathic Products - ECPv6.15.16//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://theaahp.org
X-WR-CALDESC:Events for The American Association for Homeopathic Products
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260313T110000
DTEND;TZID=America/New_York:20260313T130000
DTSTAMP:20260505T080515
CREATED:20251217T191651Z
LAST-MODIFIED:20260226T134905Z
UID:10000105-1773399600-1773406800@theaahp.org
SUMMARY:AAHP 2026 Annual Membership Meeting (and Tribute to Eric Foxman)
DESCRIPTION:AAHP GMP Compliance Virtual Seminar\n	\n	\n\n\n	\n		\n	The American Association of Homeopathic Pharmacists is excited to present a virtual seminar on Good Manufacturing Practices (GMP) for our industry. This event is open to both AAHP members and non-members. \n\n	\n\n\n\n	\n\n\n			\n	\n	\n		\n	3 Crucial Topics Discussed in Depth\nThis half-day cGMP seminar will help homeopathic manufacturers prepare for Food and Drug Administration (FDA) inspection by facilitating an understanding of compliance requirements from both the Homeopathic Pharmacopoeia of the United States (HPUS)\, Code of Federal Regulations (CFR)\, and FDA. Learn about the most pressing enforcement topics and microbiological requirements for your products. \nTamara L. Ely\, Branch Chief\, FDA Office of Manufacturing Quality\, Office of Compliance\nOverview of recent enforcement actions against homeopathic products and FDA cGMP guidance documents. \nStephen E. Langille\, Ph.D.\, Senior Microbiology Consultant at ValSource\, Inc. and former Director of FDA CDER’s Division of Microbiology Assessment\nDiscussion on one of the most common reasons for an FDA warning letter to manufacturers of homeopathic products: microbial contamination in non-sterile drug products. \nGeorge Bernstein\, Ph.D.\, Industry Consultant\nReview of easily-overlooked GMP requirements in the HPUS intended to specifically supplement pharmaceutical cGMPs for homeopathic drug products. \nBy knowing what FDA takes into consideration\, homeopathic manufacturers can better prepare for inspections and minimize their impact on day-to-day business activities. Ultimately\, this crucial education leads to manufacturing excellence and the production of the safest and highest-quality homeopathic products. \n\n	\n\n\n\n			\n	\n	\n		\n			\n					\n						Tickets\n					\n\n	\n\n\n	\n		\n			\n					\n						Agenda\n					\n\n	\n\n\n	\n		\n	Event Information\nVirtual Only\nWednesday\, Oct. 18\, 2023 from 12:00pm-4:00pm EST\nCost: $199-499\nOpen to non-members; AAHP members receive a discount. \nENTERPRISE TICKET PURCHASES: You will receive a confirmation email with instructions to register your remaining attendees following your transaction. \nWhat You Will Learn\n\nOverview and examples of inspection enforcement.\nGMP requirements specifically for homeopathic products from the HPUS.\nDesign of an effective QC program.\nMicrobiological quality standards for non-sterile products.\nFDA hot topics.\n\nWho Should Attend\nThis seminar is a must-attend for domestic and foreign firms who manufacture\, label\, pack\, or hold homeopathic drug products for sale in the United States. \n\nQuality Staff\nLegal & Regulatory Staff\nProduct Leads\nProduct R&D Staff\nCompany Leaders (President/CEO)\nAnd those similarly responsible at your contract manufacturer\n\n\n	\n\n\n\n	\n\n\n			\n	\n	\n		\n	Please contact AAHP Volunteer Communications Chair Alissa Gould via email at Alissa.Gould@Boiron.com or by voice message at 610-325-8321. \n\n	\n\n\n\n			\n	\n	\n		\n			\n					\n						Tickets\n					\n\n	\n\n\n\n	\n\n\n			\n	\n	\n		\n	Agenda\nAll times below are in Eastern Daylight Time. \n\n	\n\n\n\n	\n\n\n			\n	\n	\n		\n	\n		\n					\n					\n\n	\n		\n							\n					\n	\n\n\n	\n				12:00-12:10pm\n			\n	\n		Mark Land\, M.S.\, RAC - Welcome from AAHP			\n\n\n			\n					\n					\n\n	\n		\n							\n					\n	\n\n\n	\n				12:10-1:10pm\n			\n	\n		George Bernstein\, Ph.D. - A Look at GMP Requirements in the HPUS			\n\n\n			\n					\n					\n\n	\n		\n							\n					\n	\n\n\n	\n				1:10-1:25pm\n			\n	\n		Break			\n\n\n			\n					\n					\n\n	\n		\n							\n					\n	\n\n\n	\n				1:25-2:25pm\n			\n	\n		Stephen Langille\, Ph.D. - Microbial Contamination			\n\n\n			\n					\n					\n\n	\n		\n							\n					\n	\n\n\n	\n				2:25-2:40pm\n			\n	\n		Break			\n\n\n			\n					\n					\n\n	\n		\n							\n					\n	\n\n\n	\n				2:40-3:40pm\n			\n	\n		Tamara Ely - Compliance Trends			\n\n\n			\n					\n					\n\n	\n		\n							\n					\n	\n\n\n	\n				3:40-3:50pm\n			\n	\n		Mark Land\, M.S.\, RAC - Closing			\n\n\n			\n				\n	\n\n	\n\n\n\n	\n\n\n			\n	\n	\n		\n	About the Speakers\n\n	\n\n\n	\n		\n\n			\n			\n				\n				\n				George Bernstein\, Ph.D.\n\n									\n					\n							\n\n			\n				A Look at GMP Requirements in the HPUSPresented by George Bernstein\, Ph.D.President\, MAI Consulting\, Inc. \nGeorge Bernstein\, Ph.D.\, is President of MAI Consulting\, Inc.\, a consulting firm located in North Carolina. Dr. Bernstein has a Ph.D. in chemical engineering and more than 30 years of experience in pharmaceutical manufacturing\, laboratory operations\, data integrity\, effective training\, and quality risk management. Since 1988\, Dr. Bernstein has consulted internationally with major pharmaceutical companies. He has lectured internationally on quality systems and root cause analysis to industry trade groups\, quality organizations\, including the Parenteral Drug Association and at Interphex conferences. \nDr. Bernstein’s experience\, insights\, and innovative problem solving have been integral to his work\, which ranges from training effectiveness\, GMP compliance\, facility design\, construction\, and commissioning to business process re-engineering and process optimization. He has developed global quality standards (GLP\, GCP\, GPP) for a major international pharmaceutical company\, and has assisted many clients with audit preparation\, remediation activities\, and communications with the U.S. FDA. \nDr. Bernstein recently authored the following articles on LinkedIn: “FDA and Data Integrity — 3 Perspectives\,” “API Manufacturing and Data Integrity — an Auditor’s Perspective\,” “So\, You Want to be a Consultant? Really?” and “Training Compliance vs. Training Effectiveness.” Additionally\, Dr. Bernstein is a strong proponent of homeopathy. \n			\n		\n			\n			\n				\n				\n				Stephen E. Langille\, Ph.D.\n\n									\n					\n							\n\n			\n				Microbial ContaminationPresentation by Stephen E. Langille\, Ph.D.Senior Microbiology Consultant\, ValSource\, Inc. \nAs a senior microbiology consultant at ValSource\, Inc.\, Dr. Langille specializes in microbiological and particulate matter contamination control. Prior to this position\, he spent 19 years with FDA as a microbiology reviewer\, branch chief\, and director of the Division of Microbiology Assessment in the Center for Drug Evaluation and Research. \nDr. Langille is a member of the United States Pharmacopeia and Parenteral Drug Association working groups on particulate and microbiological manufacturing control and participating in the writing of the FDA’s draft guidance on Microbiological Quality Considerations in Non-sterile Drug Manufacturing. \nWith a B.S. degree in biology from the University of Massachusetts\, Dr. Langille earned his Ph.D. in microbiology from the University of Maryland. \n			\n		\n			\n			\n				\n				\n				Tamara L. Ely\n\n									\n					\n							\n\n			\n				Compliance TrendsPresented by Tamara L. ElyBranch Chief\, Branch 6\, Office of Manufacturing Quality\, Office of Compliance\, Center for Drug Evaluation and Research \nMs. Ely received a bachelor’s degree in chemistry from West Virginia University in 1996 and a master’s degree in quality assurance and regulatory affairs from Temple University’s School of Pharmacy in 2005. She began instructing at Temple University in 2015. As an Adjunct Associate Professor\, she co-instructs a course on Microbiological Concepts for Pharmaceuticals and Current Good Manufacturing Practices. \nIn her career\, Ms. Ely has held various quality and compliance positions within the pharmaceutical industry: analytical chemist\, certified quality auditor\, compliance reviewer\, CGMP and validation consultant. \nSince 2010\, Ms. Ely has worked in the Office of Manufacturing Quality in the Center for Drug Evaluation and Research (CDER) reviewing administrative and regulatory actions regarding adulteration\, evaluating inspectional findings\, and determining the acceptability of manufacturing facilities. In this role\, she also participates in the development of science-based regulatory policy and guidance. \n			\n		\n	\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n		Register\n	\n	\n\n\n	\n		\n	Early bird pricing is available through September 28\, 2023 at 11:59pm EDT.
URL:https://theaahp.org/event/aahp-2026-annual-membership-meeting/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://theaahp.org/wp-content/uploads/2022/05/AAHP-Logo-e1677699574756.png
ORGANIZER;CN="The American Association for Homeopathic Products":MAILTO:info@aahp.info
END:VEVENT
END:VCALENDAR